(Q40384271)

English

The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner

scientific article published on 16 August 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

0 references

cannabinoid receptor

0 references

1 reference

based on heuristic

inferred from title

human astrocyte

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Niamh M Curran

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Bryan D Griffin

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Daniel O'Toole

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kevin J Brady

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Stephen N Fitzgerald

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

16 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

280

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

35797-35806

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Inflammation in multiple sclerosis: the good, the bad, and the complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

T cells in multiple sclerosis and inflammatory central nervous system diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa B.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Loss of Ikappa B-beta is associated with prolonged NF-kappa B activity in human glial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Interleukin 1 in the brain: biology, pathology and therapeutic target

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Interleukin-1: a master regulator of neuroinflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M507959200

21 January 2018

Identifiers

10.1074/JBC.M507959200

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40384271&oldid=1896716439"